John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
BCE
BCE
$22.1B
| $64.2M | 0.28% |
1,361,639
+633,271
| +87% | +$29.3M |
|
77
Western Digital
WDC
$166B
| $64.2M | 0.28% |
1,797,028
-2,063,929
| -53% | -$68M |
|
78
Scotiabank
BNS
$107B
| $63.6M | 0.27% |
1,303,540
+1,248,141
| +2,253% | +$61.3M |
|
79
Best Buy
BBY
$18.1B
| $63.3M | 0.27% |
2,067,097
+2,038,802
| +7,206% | +$64.1M |
|
80
TechnipFMC
FTI
$30.4B
| $62.2M | 0.27% |
3,136,879
-1,118,170
| -26% | -$23.1M |
|
81
MetLife
MET
$60B
| $62M | 0.27% |
1,745,559
+1,719,174
| +6,516% | +$67M |
|
82
IQVIA
IQV
$42.8B
| $61.8M | 0.27% |
946,450
+375,516
| +66% | +$25.2M |
|
83
Williams-Sonoma
WSM
$28B
| $61.8M | 0.27% |
2,369,570
+1,425,510
| +151% | +$39.1M |
|
84
O'Reilly Automotive
ORLY
$72.1B
| $60.5M | 0.26% |
3,346,800
+2,961,825
| +769% | +$52.4M |
|
85
Biogen
BIIB
$32B
| $58.5M | 0.25% |
242,003
-1,909
| -0.8% | -$503K |
|
86
Cisco
CSCO
$438B
| $57.9M | 0.25% |
2,018,202
+535,523
| +36% | +$15M |
|
87
Kimberly-Clark
KMB
$36.4B
| $57.9M | 0.25% |
421,050
-169,013
| -29% | -$22.1M |
|
88
Nucor
NUE
$55.3B
| $57.1M | 0.25% |
1,155,797
-7,644
| -0.7% | -$373K |
|
89
Lockheed Martin
LMT
$130B
| $56.9M | 0.24% |
229,281
+155,555
| +211% | +$36.7M |
|
90
Check Point Software Technologies
CHKP
$13.3B
| $56M | 0.24% |
703,083
+691,348
| +5,891% | +$57.9M |
|
91
Analog Devices
ADI
$182B
| $55.3M | 0.24% |
975,891
+202,706
| +26% | +$11.6M |
|
92
Intel
INTC
$476B
| $54.9M | 0.24% |
1,674,573
+1,160,717
| +226% | +$36.4M |
|
93
Invesco
IVZ
$14.1B
| $54.8M | 0.24% |
2,146,612
+1,301,272
| +154% | +$38.6M |
|
|
CELG
94
DELISTED
Celgene Corp
CELG
| $54.4M | 0.23% |
551,184
+546,734
| +12,286% | +$56.6M |
|
95
Salesforce
CRM
$171B
| $54.1M | 0.23% |
681,576
+654,992
| +2,464% | +$51.4M |
|
96
Annaly Capital Management
NLY
$17.5B
| $52.6M | 0.23% |
1,187,972
+878,108
| +283% | +$37.4M |
|
|
B
97
Barrick Mining
B
$78.3B
| $52.3M | 0.22% |
2,456,323
+1,949,206
| +384% | +$34.7M |
|
|
RAD
98
DELISTED
Rite Aid Corporation
RAD
| $52M | 0.22% |
+346,969
| New | +$54.7M |
|
99
Visa
V
$693B
| $51.3M | 0.22% |
+692,227
| New | +$54.2M |
|
100
Bunge Global
BG
$21.7B
| $51.2M | 0.22% |
865,888
+19,887
| +2% | +$1.22M |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.